Product NDC: | 16590-423 |
Proprietary Name: | LOPERAMIDE HYDROCHLORIDE |
Non Proprietary Name: | LOPERAMIDE HYDROCHLORIDE |
Active Ingredient(s): | 2 mg/1 & nbsp; LOPERAMIDE HYDROCHLORIDE |
Administration Route(s): | ORAL |
Dosage Form(s): | CAPSULE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 16590-423 |
Labeler Name: | STAT Rx USA LLC |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA073192 |
Marketing Category: | ANDA |
Start Marketing Date: | 19930501 |
Package NDC: | 16590-423-20 |
Package Description: | 20 CAPSULE in 1 BOTTLE (16590-423-20) |
NDC Code | 16590-423-20 |
Proprietary Name | LOPERAMIDE HYDROCHLORIDE |
Package Description | 20 CAPSULE in 1 BOTTLE (16590-423-20) |
Product NDC | 16590-423 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | LOPERAMIDE HYDROCHLORIDE |
Dosage Form Name | CAPSULE |
Route Name | ORAL |
Start Marketing Date | 19930501 |
Marketing Category Name | ANDA |
Labeler Name | STAT Rx USA LLC |
Substance Name | LOPERAMIDE HYDROCHLORIDE |
Strength Number | 2 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Opioid Agonist [EPC],Opioid Agonists [MoA] |